The Effect of Long-term Use of Bisphosphonates on Femur Morphology
NCT06621069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2024-10-01
Summary
Recent studies have shown that bone modeling can occur throughout life, suggesting bone has a persistent ability of adapting structure to loading. Some bone medications have a significant effect on the process of bone modeling based on histological studies. Bisphosphonates (BP), a classical anti-resorption drug which impacts the process of bone turnover, is related with atypical femur fractures while the mechanism is unclear. Several hypotheses are considered competitive. Among them, increased femur bowing is associated with atypical femoral fractures. However, it remains doubtful whether long-term BP use increases femur bowing. Thus, the investigators design this retrospective cohort study.
Conditions
- Osteoporosis
- Knee Osteoarthristis
Interventions
- DRUG
-
Bisphosphonates
Alendronate Sodium or Zoledronic acid
- OTHER
-
Control
control without BP
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2024-07-01
- Completion
- 2024-08-01
Countries
- China
Study Locations
More Related Trials
-
Study of Pamidronate for the Prevention of Heterotopic Ossification
NCT00262392 ·Status: WITHDRAWN ·Phase: NA
-
The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)
NCT01020253 ·Status: UNKNOWN ·Phase: NA
-
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
NCT04719572 ·Status: UNKNOWN ·Phase: NA
-
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
NCT00666627 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty
NCT02148848 ·Status: UNKNOWN ·Phase: PHASE4
-
Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis
NCT01465568 ·Status: COMPLETED ·Phase: PHASE4
-
Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
NCT00004993 ·Status: COMPLETED ·Phase: PHASE2
-
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
NCT00460057 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
NCT00577850 ·Status: COMPLETED ·Phase: PHASE1
-
Denosumab Versus Bisphosphonates (Alendronate) in GIOP
NCT03005678 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
NCT01512446 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
NCT00145704 ·Status: TERMINATED ·Phase: NA
-
Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
NCT00445575 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis
NCT00265252 ·Status: UNKNOWN ·Phase: PHASE4
-
Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use
NCT01875458 ·Status: COMPLETED
-
A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis
NCT05067335 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis
NCT05372224 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.
NCT00266708 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese
NCT02166437 ·Status: UNKNOWN
-
Osteoporosis and Dental Implant
NCT00727493 ·Status: UNKNOWN ·Phase: PHASE4
-
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
NCT07242612 ·Status: RECRUITING ·Phase: NA
-
Osseointegrated Transdermal Femoral Amputation Prostheses
NCT05736640 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
NCT00092014 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD
NCT00752557 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
NCT04026256 ·Status: COMPLETED ·Phase: PHASE4